In fact, we found that in lung cancer over expression of BCL2 could be explained by the under expression of MIR15A, MIR16-1, and MIR16-2, while in kidney tumours over expression of DFFB, HTATIP and RELA could be related to the under expression of MIR124A-1, MIR124A-2, and MIR124A-3 (Table 5). Here, BCL2 is linked to lung carcinoma.